Strong Financial Performance: Centene reported a fourth-quarter adjusted diluted EPS of $0.80 and full-year adjusted EPS of $7.17, reflecting a 7% growth year-over-year. The company also announced a $4 billion increase in 2025 revenue guidance, now anticipating total revenues between $158 billion to $160 billion.
Medicaid Outlook: The company serves 13 million Americans in its Medicaid portfolio and anticipates improved membership stability in 2025 after navigating through post-COVID eligibility redeterminations. They expect a composite rate adjustment of 3% to 4% for the full year, supported by constructive dialogues with state partners.
Medicare Advantage Improvement: Centene's Medicare business showed progress with 55% of members being associated with 3.5-star plans or better, up significantly from 23% the previous year. The company aims for breakeven in this segment by 2027, with strong expectations for revenue growth in Medicare Part D, projected to generate approximately $16 billion in 2025.